Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia (The ReVeAL Study of the GIMEMA Working Party on Hemostasis and Thrombosis)

NCT07831668 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT07831668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia (The ReVeAL Study of the GIMEMA Working Party on Hemostasis and Thrombosis)
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2029
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, newly diagnosed acute leukemia, thromboprophylaxis, thromboprophylaxis in acute leukemia